Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-[(cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C17H16FNO2 and a molecular weight of approximately 285.31 g/mol. It features a quinoline core substituted with fluorine, isopropyl, and cyclopropylethynyloxy groups. The compound has been referenced in chemical databases as an experimental or research molecule but does not have any known clinical use or approved therapeutic indication. Its mechanism of action, biological targets, and pharmacological properties are not described in public drug databases or scientific literature as of June 2025[1][5][9]. It is classified structurally among fluoroquinolones but does not appear to be developed for antibacterial use like typical members of this class.
- Other names
- 4-((cyclopropylethynyl)oxy)-6-fluoro-3-isopropylquinolin-2(1H)-one4-(2-cyclopropylethynoxy)-6-fluoro-3-propan-2-ylquinolin-2-one4-[ (2-cyclopropylethynyl)oxy ] -6-fluoro -3-(propan -2 -yl ) -1,2-dihydroquinolin -2-oneGW745XGW-745XGW 745X
Beyond the preview
Go deeper on 4-[(cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-[(cyclopropylethynyl)oxy]-6-fluoro-3-isopropylquinolin-2(1H)-one.